Guy's ,Would like to sqeeze a few more Drachmas out this latest of movements, please try to encourage further upward motion. Thanks for all past performances, and good luck as well
psdv proxy -raising some additional funds, asking to increase # shares. I voted yes to first and no to second request. when the company announces successful medidur results, if the stock price jumps that may be a good opportunity to sell. they are going to bleed money before they make money. ...
The scenarios are quite interesting at current levels for PSDV. Do you guys find it difficult to know when to buy or sell something? I prefer to get my stocks from awesome-STOCKS.
Dr de Cogan said: "The CPP-drug has the potential to have a significant impact on the treatment of AMD by revolutionising drug-delivery options.
"Efficacious self-administered drug application by eye drop would lead to a significant reduction in adverse outcomes and health care costs compared with current treatments.
"The CPP-plus drug complex also has potential application to other chronic ocular diseases that require drug delivery to the posterior chamber of the eye.
Scientists develop revolutionary eye drops to treat age-related blindness
Scientists at the University of Birmingham have developed a type of eye drop which could potentially revolutionise the treatment of one of the leading causes of blindness in the UK.
not sure why the stock spiked today -the conf. call was straight forward -maybe that was enough to say things are on track - not complaining - stock is undervalued to some extent - will move higher with successful medidur results...
Makes me crazy pSivida tapped out their ATM, then asks for a special proxy to do the same again. They're either brilliant or something other than brilliant. That's balls in my opinion, after all, the last fund raise went south by 50% in a year and a half. No question Jaffe's presentation at ARVO will get noticed and it just might be the best of breed for posterior uveitis, managing a difficult back of the eye disease with "daily micro-dosing" for three years. Somethings happening.....obviously.
X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks May-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is 0.7 In other words, the correlation coefficient of the other stock
nice momentum heading into medidur results ...
There is rely one one question that matters: Are company insiders/directors buying stock in the open market?
Conference call - anything about the sales numbers for Iluvien. Did Psivida get any royalty payment from Alimera this Quarter and how much compare to last quarter ?
There are bunch of warrants expiring in July with average strike price of 2.50.
Once these expire the stock will move until then, I am not sure if there is going to be substantial gains.
Is there funding needs in the near future for this company?
any opinions on the cash position?
DO NOT SELL YOUR SHARES SO CHEAP !!!!!! Check PSDV website.... hedgefund or private company buyer is accumulating shares for someone or some company.... 13G form filed ..... check it out.
I also read the 13 G but it has 6.2% ownership interest.where do you see 18% ownership filing data?
ALIM upgrade today ....pt $4 ...
shorts are back
I am intrigued by the heavy volume with no appreciable increase in sp. So perhaps Rosalind advisors continues its accumulation. Earnings early May and then mid-May the presentations on Medidur.
Until volatility increases, its hard to see price move in one direction or other.
It seems like they need to raise capital soon, but the stock price is kept in check for some reason. ALIM seems to be breaking out here not sure why this stock is not moving higher ?!?!?!
SHORTS ARE COVERING at prices way to cheap... January short interest was 2.34, dropped to 1.71 in March and today short interest is 0.65 Rosalind group who has been buying recently for someone now owns 18.7% of shares on 13G filed. Should see share price going up soon. Comments please
Is there a capital raise in the near future for this company? moe dilution or a debt offering ??
To all the longs be aware there is now a 13G, can be accessed on pSiveda website, Report is dated April 5, 2017 and shows accumulation of 18.7 % of shares of PSDV by 3 related buyers all attached to same 13G. Seems to me they are buying for someone else... either PSDV or ????? That answers why vol. is high and price not moving.... Hang on here guys, I have been long for years, just don't post much. Would be interested in what the main posters here have to say about this...